Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Imlifidase for Highly Sensitized Kidney Transplant Recipients With a posItive crossmAtch Against a Deceased Donor: Results of Kidney Transplantations Performed in Accordance to the French Guidelines.

NCT07379957 is registered in ClinicalTrials.gov with University Hospital, Bordeaux as lead sponsor.

NCT NCT07379957
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07379957 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Imlifidase for Highly Sensitized Kidney Transplant Recipients With a posItive crossmAtch Against a Deceased Donor: Results of Kidney Transplantations Performed in Accordance to the French Guidelines.
Lead sponsor
University Hospital, Bordeaux
Phase
Observational
Overall status
Not yet recruiting
Start date
January 31, 2026
Completion date
February 28, 2029
Enrollment
450 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplantation